Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different doses of butorphanol for postoperative analgesia after repeat cesarean section
ChiCTR2000032449Phase 4Recruiting
- Sponsor
- Hengyang Central Hospital
- Start
- Jan 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of butorphanol and sufentanil in postoperative pain (4 arms), sponsored by Hengyang Central Hospital. Primary endpoints: Visual Analogue Score, Nausea and vomiting and 3 more. Started Jan 2020; status: recruiting.
02
Drugs
butorphanolsufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2000032449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032449.